agena-bioscience-logo
  • Technology
  • Applications
  • Resources
  • Support
  • Company
  • Contact
EN - Global CN - 中国

menu

agena-bioscience-logo agena-bioscience-logo Close
  • Home
  • Technology
  • Applications
    • Pharmacogenetics
    • Liquid Biopsy
    • Mutation Profiling
    • Hereditary Genetics
    • Methylation
    • Sample Integrity
    • Specimen Validity
  • Services
    • Assays by Agena
    • Certified Service Providers
  • Resources
    • Product Literature
    • Publication Library
  • Support
    • Service Plans
    • Distributors
    • Certified Service Providers
  • Company
    • Careers
    • Press
  • Contact
  • Customer Support Portal
  • Home
  • Technology
  • Applications
    • Pharmacogenetics
    • Mutation Profiling
    • Liquid Biopsy
    • Hereditary Genetics
    • Methylation
    • Sample Integrity
    • Specimen Validity
  • Services
    • Assays by Agena
    • Certified Service Providers
  • Resources
    • Product Literature
    • Publication Library
  • Support
    • Service Plans
    • Distributors
    • Certified Service Providers
  • Company
    • Careers
    • Press
  • Contact
  • Customer Support Portal

Phone: (858) 882-2800

Home / Resources / Publication Library

Search Results for: Mutation Profiling

Search All publications

How recent?
  • Invasive Lobular Carcinoma Mimicking Encapsulated Papillary Carcinoma with a Literature Review: A Rare Variant Detected Serendipitously
  • Energy balance-related factors and risk of colorectal cancer based on KRAS, PIK3CA, and BRAF mutations and MMR status
  • Molecular Signatures of KRAS-Mutated Lung Adenocarcinoma: Analysis of Concomitant EGFR, ALK, STK11, and PD-L1 Status
  • Anchored Multiplex PCR Custom Melanoma Next Generation Sequencing Panel for Analysis of Circulating Tumor DNA
  • Development and evaluation of ActSeq: A targeted next-generation sequencing panel for clinical oncology use
  • Identification of BRAF V600E mutation in odontogenic tumors by high-performance MALDI-TOF analysis
  • The Difference in Clinical Outcomes Between Osimertinib and Afatinib for First-Line Treatment in Patients with Advanced and Recurrent EGFR-Mutant Non-Small Cell Lung Cancer in Taiwan
  • Diabetes mellitus in relation to colorectal tumor molecular subtypes‐a pooled analysis of more than 9,000 cases
  • Single-cell landscapes of primary glioblastomas and matched explants and cell lines show variable retention of inter-and intratumor heterogeneity
  • Detection of TERT Promoter Mutations as a Prognostic Biomarker in Gliomas: Methodology, Prospects, and Advances
«...45678...203040...»
Products
  • Technology
  • Applications
  • Custom Assays
Resources
  • Product Literature
  • Publication Library
  • ISO Certifications
  • Patents
    Support
    • Support Contacts
    • Service Plans
    • Certified Service Providers
    • Distributors
    • Customer Support Portal
Company
  • About Us
  • Careers
  • Contact
footer-logo
Agena Bioscience

4755 Eastgate Mall,
San Diego, CA 92121

(877) 443-6663

With exception of the MassARRAY Dx, all other products are For Research Use Only. Not for use in diagnostic procedures.
© 2020-2025 Agena Bioscience, Inc. All rights reserved. Agena Bioscience is a subsidiary of Mesa Labs, Inc.

  • footer-mesalabs-logo
  • footer-protein-logo
  • footer-gke-logo
  • Privacy Policy
  • Website Terms & Conditions
  • Product Terms & Conditions
  • Warranty